We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Handheld Nanopore DNA Sequencer Rapidly Detects Viral Infections in Blood Samples

By LabMedica International staff writers
Posted on 11 Oct 2015
Print article
Image: Close up of the MinION nanopore sequencer (Photo courtesy of Dr. Andrew Kilianski, Edgewood Chemical Biological Center).
Image: Close up of the MinION nanopore sequencer (Photo courtesy of Dr. Andrew Kilianski, Edgewood Chemical Biological Center).
A handheld nanopore DNA sequencer was used to accurately identify and differentiate viruses in patient blood samples with an unprecedented sample-to-answer turnaround time of less than six hours.

The Oxford Nanopore Technologies (Oxford, United Kingdom) MinION nanopore sequencer rapidly determines the sequence of subject DNA through the application of protein nanopore technology. The method is based on a protein channel—only a few nanometers in diameter—through which a single strand of DNA can pass. As the DNA strand passes through the nanopore, it generates a series of characteristic electrical signatures, from which nucleotide bases can be identified, and the sequence of the strand determined. The instrument is powered and operated by a laptop computer via a USB connection.

Investigators at the University of California, San Francisco (USA; www.ucsf.edu) used a MinION instrument to analyze blood samples from four patients for Chikungunya virus (CHIKV), Ebolavirus (EBOV), and Hepatitis C virus (HCV).

They reported that at high titers ranging from 107 to 108 copies per milliliter, reads to EBOV from two patients with acute hemorrhagic fever and CHIKV from an asymptomatic blood donor were detected within 4 to 10 minutes of data acquisition, while lower titer HCV virus (1x105 copies per milliliter) was detected within 40 minutes. Confirmation of results was obtained by sequencing with an Illumina Inc. (San Diego, CA, USA) MiSeq instrument.

Nanopore sequencing is a third-generation sequencing technology that has two key advantages over second-generation technologies—longer reads and the ability to perform real-time sequence analysis. As of mid-2015, the MinION nanopore sequencer was capable of producing at least 100,000 sequences with an average read length of five kilobases, in total producing up to one gigabase of sequence in 24 hours on one flow cell.

In the current study, the investigators presented nanopore sequencing for metagenomic detection of viral pathogens from clinical samples with a sample-to-answer turnaround time of less than six hours. They also introduced MetaPORE, a real-time web-based sequence analysis and visualization tool for pathogen identification from nanopore data.

“To our knowledge, this is the first time that nanopore sequencing has been used for real-time metagenomic detection of pathogens in complex clinical samples in the setting of human infections,” said senior author Dr. Charles Y Chiu, associate professor of laboratory medicine at the University of California, San Francisco. “Unbiased point-of-care testing for pathogens by rapid metagenomic sequencing has the potential to radically transform infectious disease diagnosis in both clinical and public health settings. This point-of-care genomic technology will be particularly attractive in the developing world, where critical resources, including reliable electric power, laboratory space, and computational server capacity, are often severely limited.

The study was published in the September 29, 2015, online edition of the journal Genome Medicine.

Related Links:

Oxford Nanopore Technologies
University of California, San Francisco
Illumina Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.